INMD · InMode Ltd.
Market Cap
$781.45M
Shares
57.54M
Volume · Oct 27
451.59K
Avg daily vol (3M)
477.78K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$13.58
Open$13.73
Day$13.57–13.80
52W close$12.76–16.62
Avg vol 30d473K
Short int2.2M · 3.9% float · 4.8d
Short vol45%
Last earningsMay 6, 2026
DataJan 2020–Oct 2026
Up next
call held May 6, 2026
Latest filings
6-K
filed Oct 26, 2026
On October 26, 2026, InMode Ltd.’s Special Committee said it remains active and independently reviewing acquisition proposals and other strategic alternatives. In the current process, no party has agreed to enter into a non-disclosure agreement; no transaction is assured.
Read the 6-K
20-F
filed Feb 10, 2026
Read the 20-F
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
+10.6%
Year over year
Operating margin
23.0%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-18.8%
Year over year · fewer shares
Price change (1Y)
-13.2%
Trailing year
Short interest
3.9%
Latest settlement · 4.8 days to cover
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Low
Market backdrop
VIX 17.5 · elevated
Equity put/call 0.59
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−5%
below
Price vs 50-day avg
−6%
below
RSI (14)
26
oversold
MACD trend
Negative
52-week position
21%
mid-range
Momentum
relative strength
1-month return
−5%
trailing
6-month return
0%
trailing
YTD return
−8%
this year
Relative strength
−5%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $14 › 200d $14 — 50d above 200d
Institutional flow
Distributing
34 of 190 funds reported for Sep 30 · net -249.2K sh shares · +6 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
3.86% of float · ▼ -1.5% MoM · 4.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
190 holders — near 3-yr low, contrarian setup
Squeeze score
54
elevated · 0–100
Fundamentals
Revenue growth
−6%
Y/Y
Gross margin
79%
contracting
EPS growth
−36%
Y/Y
Free cash flow
$84.3M
Balance sheet
$302.5M
net cash
Quant / Vol
risk profile
Volatility
30%
annualized · 1-yr
Max drawdown
−23%
past year
ATR
1.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed May 6, 2026
Revenues
· 2026
$365M – $375M
prior FY $370.5M
midpoint −0.1% Y/Y
Non-GAAP gross margin
· 2026
Non-GAAP
74% – 76%
Non-GAAP income from operations
· 2026
Non-GAAP
$73M – $78M
Prior guidance
period ended
· from the Earnings Call filed Nov 5, 2025
Revenues
· 2025
$365M – $375M
Non-GAAP gross margins
· 2025
78% – 80%
Non-GAAP income from operations
· 2025
$93M – $98M
Non-GAAP earnings per diluted share
· 2025
$1.55 – $1.59
Guided vs delivered
· last 4 settled
Revenues
2025
guided $365M – $375M
$370.5M
In line
China revenue (quarterly run-rate)
next year
guided $4M
$454.27M
Beat +11256.8%
Total revenue
full-year 2021
guided $305M – $315M
$357.57M
Beat +15.3%
Full-year 2020 revenue guidance
full-year 2020
guided $192M – $195M
$206.11M
Beat +6.5%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−5%
Bearish
Price vs 50-day avg
−6%
Bearish
RSI (14)
26
Neutral
MACD trend
Negative
Bearish
52-week position
21%
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $14 › 200d $14 — 50d above 200d
Institutional flow
Distributing
34 of 190 funds reported for Sep 30 · net -249.2K sh shares · +6 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
3.86% of float · ▼ -1.5% MoM · 4.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
190 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $13
Now $14 · 21%
Range high $17
vs 200-day avg -5%
vs 50-day avg -6%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
INMD
this stock
InMode Ltd.
|
$781.45M | -7.6% | -6.2% | — | 3.9% |
|
ABT
Abbott Laboratories
|
$179.99B | -17.7% | +5.7% | 33.4 | 1.0% |
|
MDT
Medtronic plc
|
$120.18B | -2.2% | +8.4% | 23.1 | 10.9% |
|
SYK
Stryker Corp
|
$115.17B | -14.2% | +11.2% | 31.1 | 1.5% |
|
BSX
Boston Scientific Corp
|
$65.30B | -52.7% | +12.5% | 18.2 | 2.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
SEC Filings
Latest
6-K
- Filed
- Oct 26, 2026
- This year
- 20
On October 26, 2026, InMode Ltd.’s Special Committee said it remains active and independently reviewing acquisition proposals and other strategic alternatives. In the current process, no party has agreed to enter into a non-disclosure agreement; no transaction is assured.
ViewEarnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| INMD | -4.0% | -4.5% | -0.1% | -4.2% | -7.6% |
| SPY | +0.1% | +0.7% | +4.9% | +0.9% | +12.9% |
| vs SPY | -4.0% | -5.2% | -5.0% | -5.1% | -20.4% |
Key facts
CIK
1742692
CUSIP
M5425M103
13F (30d)
27 filings
27 filers
Visit website
Investor relations